期刊
BIOMACROMOLECULES
卷 16, 期 11, 页码 3425-3433出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.biomac.5b00643
关键词
-
资金
- Agence Nationale de la Recherche (grant DENDRI'MS) [ANR-RPIB-2011-005]
- Association pour la Recherche sur la Sclerose en Plaques (ARSEP)
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Centre National de la Recherche Scientifique (CNRS)
- University of Toulouse
Dendrimers are polyfunctional nano-objects of perfectly defined structure that can provide innovative alternatives for the treatment of chronic inflammatory diseases, including multiple sclerosis (MS). To investigate the efficiency of a recently described amino-bis(methylene phosphonate)capped ABP dendrimer as a potential drug candidate for MS, we used the classical mouse model of MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAR). Our study provides evidence that the ABP dendrirner prevents the development of EAR and inhibits the progression of established disease with a comparable therapeutic benefit as the approved treatment Fingolimod. We also show that the ABP dendrimer redirects the pathogenic myelin-specific CD4(+) T cell response toward IL-10 production.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据